Progress in molecular targeted therapy for thyroid cancer: vandetanib in medullary thyroid cancer.
Solomon B; Rischin D; Journal Of Clinical Oncology: Official Journal Of The American Society Of Clinical Oncology, 2012, vol. 30, issue 2, p 119, ISSN 15277755. ISBN 15277755.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef